BackAkums Drugs & Pharmaceuticals Overview

Akums Drugs & Pharmaceuticals Goodwill

Track Akums Drugs & Pharmaceuticals's goodwill ($21M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$20.63M
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Akums Drugs & Pharmaceuticals Goodwill History

Loading

Akums Drugs & Pharmaceuticals vs. peers: Goodwill Comparison

Loading

Akums Drugs & Pharmaceuticals Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Akums Drugs & Pharmaceuticals (AKUMS.NS) FAQ

Akums Drugs & Pharmaceuticals (AKUMS.NS) currently reports a goodwill of $21M as of March 2026. That compares with $21M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Akums Drugs & Pharmaceuticals's goodwill history and peer comparisons.

Akums Drugs & Pharmaceuticals's goodwill was unchanged from $21M to $21M — essentially flat versus a year earlier (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Akums Drugs & Pharmaceuticals reported $21M in goodwill as of March 2026. That compares with $21M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $21M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Akums Drugs & Pharmaceuticals, and consider following AKUMS.NS for alerts when major investors trade the stock.